257 related articles for article (PubMed ID: 10520178)
21. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
Schaible UE; Winau F; Sieling PA; Fischer K; Collins HL; Hagens K; Modlin RL; Brinkmann V; Kaufmann SH
Nat Med; 2003 Aug; 9(8):1039-46. PubMed ID: 12872166
[TBL] [Abstract][Full Text] [Related]
22. CD1 and major histocompatibility complex II molecules follow a different course during dendritic cell maturation.
van der Wel NN; Sugita M; Fluitsma DM; Cao X; Schreibelt G; Brenner MB; Peters PJ
Mol Biol Cell; 2003 Aug; 14(8):3378-88. PubMed ID: 12925770
[TBL] [Abstract][Full Text] [Related]
23. Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions.
Sieling PA; Ochoa MT; Jullien D; Leslie DS; Sabet S; Rosat JP; Burdick AE; Rea TH; Brenner MB; Porcelli SA; Modlin RL
J Immunol; 2000 May; 164(9):4790-6. PubMed ID: 10779786
[TBL] [Abstract][Full Text] [Related]
24. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes.
Porcelli S; Brenner MB; Greenstein JL; Balk SP; Terhorst C; Bleicher PA
Nature; 1989 Oct; 341(6241):447-50. PubMed ID: 2477705
[TBL] [Abstract][Full Text] [Related]
25. The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells.
Pargass IS; Wills TB; Davis WC; Wardrop KJ; Alperin DC; Hines SA
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):197-209. PubMed ID: 19285733
[TBL] [Abstract][Full Text] [Related]
26. Four pathways of CD1 antigen presentation to T cells.
Moody DB; Cotton RN
Curr Opin Immunol; 2017 Jun; 46():127-133. PubMed ID: 28756303
[TBL] [Abstract][Full Text] [Related]
27. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation.
Mawhorter SD; Kazura JW; Boom WH
Immunology; 1994 Apr; 81(4):584-91. PubMed ID: 7518797
[TBL] [Abstract][Full Text] [Related]
28. Presentation of soluble and bacterial antigens by milk-derived cells to unprimed bovine T cells in vitro.
Fitzpatrick JL; Williams NA; Bailey M; Bland PW; Stokes CR
Vet Immunol Immunopathol; 1995 Jun; 46(3-4):251-66. PubMed ID: 7502486
[TBL] [Abstract][Full Text] [Related]
29. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
30. Isolation of a new superantigen with potent mitogenic activity to murine T cells from Streptococcus pyogenes.
Nemoto E; Rikiishi H; Sugawara S; Okamoto S; Tamura K; Maruyama Y; Kumagai K
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):81-91. PubMed ID: 8880132
[TBL] [Abstract][Full Text] [Related]
31. In vivo modulation of CD1 and MHC class II expression by sheep afferent lymph dendritic cells. Comparison of primary and secondary immune responses.
Hopkins J; Dutia BM; Bujdoso R; McConnell I
J Exp Med; 1989 Oct; 170(4):1303-18. PubMed ID: 2477489
[TBL] [Abstract][Full Text] [Related]
32. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.
Barzaga-Gilbert E; Grass D; Lawrance SK; Peterson PA; Lacy E; Engelhard VH
J Exp Med; 1992 Jun; 175(6):1707-15. PubMed ID: 1534116
[TBL] [Abstract][Full Text] [Related]
33. Major histocompatibility complex restriction of tetanus toxoid-specific human T lymphocyte clones.
Schmitt C; Cogné M; Agrapart M; Ballet JJ
Eur J Immunol; 1984 Dec; 14(12):1131-6. PubMed ID: 6083872
[TBL] [Abstract][Full Text] [Related]
34. Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice.
Formby B; Miller N
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2438-42. PubMed ID: 2138777
[TBL] [Abstract][Full Text] [Related]
35. CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.
Roura-Mir C; Catálfamo M; Cheng TY; Marqusee E; Besra GS; Jaraquemada D; Moody DB
J Immunol; 2005 Mar; 174(6):3773-80. PubMed ID: 15749918
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of lipid antigen presentation by CD1.
Jackman RM; Moody DB; Porcelli SA
Crit Rev Immunol; 1999; 19(1):49-63. PubMed ID: 9987600
[TBL] [Abstract][Full Text] [Related]
37. CD1 presents antigens from a gram-negative bacterium, Haemophilus influenzae type B.
Fairhurst RM; Wang CX; Sieling PA; Modlin RL; Braun J
Infect Immun; 1998 Aug; 66(8):3523-6. PubMed ID: 9673229
[TBL] [Abstract][Full Text] [Related]
38. Diverse antigen presentation by the Group 1 CD1 molecule, CD1c.
Adams EJ
Mol Immunol; 2013 Sep; 55(2):182-5. PubMed ID: 23127489
[TBL] [Abstract][Full Text] [Related]
39. T lymphocyte recognition of human group 1 CD1 molecules: implications for innate and acquired immunity.
Sugita M; Brenner MB
Semin Immunol; 2000 Dec; 12(6):511-6. PubMed ID: 11145856
[TBL] [Abstract][Full Text] [Related]
40. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
